Sulindac as a precision microRNA modulator in early-stage K-Ras-driven oncogenesis
Christos Adamopoulos, Kostas A. Papavassiliou, Athanasios G. Papavassiliou · 2025
Read Sulindac as a precision microRNA modulator in early-stage K-Ras-driven oncogenesis by Christos Adamopoulos, Kostas A. Papavassiliou, Athanasios G. Papavassiliou (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12669605.txt.
Description
tal and other cancers [1]. Their effects extend beyond cyclo-oxygenase (COX) blockade, implicating COX-independent mechanisms such as modulation of apoptosis, signal transduction, immune responses, and even microRNA (miRNA) regulation [2, 3]. This expanded perspective has revived attention to NSAIDs as versatile agents in cancer chemoprevention, especially as resistance and heterogeneity limit targeted regimens.
Catalog record
| CREATOR | Christos Adamopoulos, Kostas A. Papavassiliou, Athanasios G. Papavassiliou |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |